MTD vs OMCL: fair value comparison
Mettler-Toledo International Inc. and Omnicell, Inc. · Updated 2026-08-31
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, MTD currently sits closer to the top of our discount ranking. MTD carries the stronger quality grade.
| MTD | OMCL | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $1,398.58 | $37.65 |
| 12-month range | $1,183.57–$1,468.09 | $29.96–$48.70 |
| Sector rank | #51 of 113 Healthcare | #52 of 113 Healthcare |
| Quality grade | B | D |
| Momentum grade | D | — |
| Leverage | Low | Low |
| Margin trend | Stable | — |
| Revenue growth | Declining | — |
| RSI zone | Neutral | Oversold |
| 50/200-day trend | — | Downtrend |
| DCF cross-check | Overvalued | — |
| 52-week position | The top quarter | The lower-middle quarter |
Full single-stock breakdowns: MTD fair value analysis · OMCL fair value analysis